Radiation Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2025-11-17
EMA Authorised: Imreplys (sargramostim) — Partner Therapeutics Limited
The European Medicines Agency authorised Imreplys (sargramostim) for acute radiation syndrome, with Partner Therapeutics Limited as the mark…